Orchestra BioMed Holdings, Inc. (OBIO)
USD 4.76
(-3.64%)
USD 4.76
(-3.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 2.76 Million | 3.53 Million | -782 Thousand | 5.7 Million |
| Cost of Revenue | 186 Thousand | 322 Thousand | 199 Thousand | 145 Thousand |
| Gross Profit | 2.57 Million | 3.21 Million | -981 Thousand | 5.55 Million |
| Operating Expenses | 54.08 Million | 35.86 Million | 20.81 Million | 24.31 Million |
| Selling, General and Administrative Expenses | 20.25 Million | 13.92 Million | 7.92 Million | 10.83 Million |
| Research and Development Expenses | 33.82 Million | 21.94 Million | 12.89 Million | 13.47 Million |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 54.26 Million | 36.19 Million | 21.01 Million | 24.45 Million |
| Operating Income | -51.5 Million | -32.65 Million | -21.79 Million | -18.75 Million |
| Interest Expense | - | - | 927 Thousand | - |
| Income Tax Expense | - | -221.99 Thousand | 927 Thousand | 2.6 Million |
| Earnings before Tax | -49.12 Million | -33.6 Million | -23.01 Million | -21.35 Million |
| Net Income | -49.12 Million | -33.6 Million | -23.01 Million | -21.35 Million |
| Earnings Per Share Basic | -1.48 | -2.24 | -1.13 | -1.04 |
| Earnings Per Share Diluted | -1.48 | -2.24 | -1.13 | -1.04 |
| Weighted Average Shares Outstanding | 33.22 Million | 14.98 Million | 20.45 Million | 20.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.22 Million | 14.98 Million | 20.45 Million | 20.45 Million |
| Gross Margin | 0.93 | 0.91 | 1.25 | 0.97 |
| EBIT Margin | -18.56 | -9.18 | 27.64 | -2.75 |
| Profit Margin | -17.80 | -9.51 | 29.43 | -3.74 |
| EBITDA | -51.21 Million | -32.43 Million | -21.61 Million | -18.61 Million |
| Earnings Before Tax Margin | -18.66 | -9.24 | 27.88 | -3.29 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 778 Thousand | 620 Thousand | 2.76 Million | 262 Thousand | 419 Thousand | 915 Thousand |
| Cost of Revenue | 118 Thousand | 108 Thousand | 329.5 Thousand | 83 Thousand | 41 Thousand | 54 Thousand |
| Gross Profit | 660 Thousand | 512 Thousand | 2.43 Million | 179 Thousand | 378 Thousand | 861 Thousand |
| Operating Expenses | 17.51 Million | 14.93 Million | 53.93 Million | 12.66 Million | 14.9 Million | 13.81 Million |
| Selling, General and Administrative Expenses | 6.39 Million | 5.82 Million | - | 4.14 Million | 6.34 Million | 5.31 Million |
| Research and Development Expenses | 11.12 Million | 9.11 Million | - | 8.51 Million | 8.55 Million | 8.49 Million |
| Other Expenses | - | -11 Thousand | - | - | - | - |
| Cost and Expenses | 17.63 Million | 15.04 Million | 54.26 Million | 12.74 Million | 14.94 Million | 13.87 Million |
| Operating Income | -16.85 Million | -14.42 Million | -51.5 Million | -12.48 Million | -14.52 Million | -12.95 Million |
| Interest Expense | - | - | - | -351 Thousand | - | - |
| Income Tax Expense | - | 30.72 Thousand | 119.1 Thousand | 2.72 Million | -1.2 Million | -910 Thousand |
| Earnings before Tax | -15.98 Million | -13.46 Million | -49.12 Million | -12.81 Million | -13.31 Million | -12.04 Million |
| Net Income | -15.98 Million | -13.46 Million | -49.12 Million | -12.81 Million | -13.31 Million | -12.04 Million |
| Earnings Per Share Basic | -0.45 | -0.38 | - | -0.36 | -0.38 | -0.35 |
| Earnings Per Share Diluted | -0.45 | -0.38 | - | -0.36 | -0.38 | -0.35 |
| Weighted Average Shares Outstanding | 35.8 Million | 35.77 Million | 33.22 Million | 35.77 Million | 35.24 Million | 34.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.8 Million | 35.77 Million | 33.22 Million | 35.77 Million | 35.24 Million | 34.61 Million |
| Gross Margin | 0.85 | 0.83 | 0.88 | 0.68 | 0.90 | 0.94 |
| EBIT Margin | -21.57 | -23.14 | - | -47.36 | -35.19 | -14.05 |
| Profit Margin | -20.54 | -21.71 | -17.80 | -48.92 | -31.78 | -13.17 |
| EBITDA | -16.78 Million | -14.34 Million | - | -12.4 Million | -14.74 Million | -12.85 Million |
| Earnings Before Tax Margin | -21.67 | -23.26 | -18.66 | -47.64 | -34.66 | -14.16 |
MDPR
DIANATEA
ZDGGF
PX
SABTNL
183490